Viewing Study NCT00114257


Ignite Creation Date: 2025-12-24 @ 6:48 PM
Ignite Modification Date: 2025-12-27 @ 11:23 AM
Study NCT ID: NCT00114257
Status: COMPLETED
Last Update Posted: 2013-02-11
First Post: 2005-06-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Decitabine and FR901228 in Treating Patients With Relapsed or Refractory Leukemia, Myelodysplastic Syndromes, or Myeloproliferative Disorders
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module